Orwa Dandash
Orwa Dandash
Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia
Search for other papers by Orwa Dandash in
Google Scholar
PubMed
Search for other papers by Orwa Dandash in
Google Scholar
PubMed
James Allebone
James Allebone
Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia
Search for other papers by James Allebone in
Google Scholar
PubMed
Search for other papers by James Allebone in
Google Scholar
PubMed
Adam Mirabelli
Adam Mirabelli
Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia
Search for other papers by Adam Mirabelli in
Google Scholar
PubMed
Search for other papers by Adam Mirabelli in
Google Scholar
PubMed
Nicholas Russell
Nicholas Russell
Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia
Search for other papers by Nicholas Russell in
Google Scholar
PubMed
Search for other papers by Nicholas Russell in
Google Scholar
PubMed
Mathis Grossmann
Mathis Grossmann
Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia
Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
Andrea Gogos
Andrea Gogos
Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia
Department of Florey Institute, University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Andrea Gogos in
Google Scholar
PubMed
Department of Florey Institute, University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Andrea Gogos in
Google Scholar
PubMed
Richard A Kanaan
Richard A Kanaan
Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia
Search for other papers by Richard A Kanaan in
Google Scholar
PubMed
Search for other papers by Richard A Kanaan in
Google Scholar
PubMed
supporting the effect of ADT on emotional regulation and affect however, is less clear ( 11 ). In a randomized controlled trial there was no difference in depressive symptoms between hypogonadal patients receiving testosterone and patients receiving placebo
Vita Birzniece
Vita Birzniece
School of Medicine, Western Sydney University, New South Wales, Australia
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Garvan Institute of Medical Research, New South Wales, Australia
School of Medical Sciences, University of New South Wales, New South Wales, Australia
Search for other papers by Vita Birzniece in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Garvan Institute of Medical Research, New South Wales, Australia
School of Medical Sciences, University of New South Wales, New South Wales, Australia
Search for other papers by Vita Birzniece in
Google Scholar
PubMed
Teresa Lam
Teresa Lam
School of Medicine, Western Sydney University, New South Wales, Australia
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Department of Diabetes and Endocrinology, Westmead Hospital, New South Wales, Australia
Search for other papers by Teresa Lam in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Department of Diabetes and Endocrinology, Westmead Hospital, New South Wales, Australia
Search for other papers by Teresa Lam in
Google Scholar
PubMed
Mark McLean
Mark McLean
School of Medicine, Western Sydney University, New South Wales, Australia
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Search for other papers by Mark McLean in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Search for other papers by Mark McLean in
Google Scholar
PubMed
Navneeta Reddy
Navneeta Reddy
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Search for other papers by Navneeta Reddy in
Google Scholar
PubMed
Search for other papers by Navneeta Reddy in
Google Scholar
PubMed
Haleh Shahidipour
Haleh Shahidipour
School of Medicine, Western Sydney University, New South Wales, Australia
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Search for other papers by Haleh Shahidipour in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Search for other papers by Haleh Shahidipour in
Google Scholar
PubMed
Amy Hayden
Amy Hayden
School of Medicine, Western Sydney University, New South Wales, Australia
Faculty of Medicine, Health and Human Sciences, Macquarie University, New South Wales, Australia
Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia
Search for other papers by Amy Hayden in
Google Scholar
PubMed
Faculty of Medicine, Health and Human Sciences, Macquarie University, New South Wales, Australia
Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia
Search for other papers by Amy Hayden in
Google Scholar
PubMed
Howard Gurney
Howard Gurney
Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia
Search for other papers by Howard Gurney in
Google Scholar
PubMed
Search for other papers by Howard Gurney in
Google Scholar
PubMed
Glenn Stone
Glenn Stone
School of Computing, Engineering and Mathematics, Western Sydney University, New South Wales, Australia
Search for other papers by Glenn Stone in
Google Scholar
PubMed
Search for other papers by Glenn Stone in
Google Scholar
PubMed
Rikke Hjortebjerg
Rikke Hjortebjerg
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Steno Diabetes Center Odense, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Search for other papers by Rikke Hjortebjerg in
Google Scholar
PubMed
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Steno Diabetes Center Odense, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Search for other papers by Rikke Hjortebjerg in
Google Scholar
PubMed
Jan Frystyk
Jan Frystyk
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Search for other papers by Jan Frystyk in
Google Scholar
PubMed
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Search for other papers by Jan Frystyk in
Google Scholar
PubMed
12615000778583). Experimental design Fifteen patients were randomised to receive either metformin or placebo first using a computer random assignment programme. Each treatment was for 6 weeks. Study endpoints were assessed at baseline, after 6 weeks of
Daniel Alexander Hescheler
Daniel Alexander Hescheler
Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
European Institute for Molecular Imaging (EIMI), University of Münster, Münster, Germany
Search for other papers by Daniel Alexander Hescheler in
Google Scholar
PubMed
European Institute for Molecular Imaging (EIMI), University of Münster, Münster, Germany
Search for other papers by Daniel Alexander Hescheler in
Google Scholar
PubMed
Milan Janis Michael Hartmann
Milan Janis Michael Hartmann
Department of General, Visceral, Tumor and Transplant Surgery, University Hospital Cologne, Cologne, Germany
Search for other papers by Milan Janis Michael Hartmann in
Google Scholar
PubMed
Search for other papers by Milan Janis Michael Hartmann in
Google Scholar
PubMed
Burkhard Riemann
Burkhard Riemann
Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
Search for other papers by Burkhard Riemann in
Google Scholar
PubMed
Search for other papers by Burkhard Riemann in
Google Scholar
PubMed
Maximilian Michel
Maximilian Michel
Institute of Zoology, University of Cologne Germany, Cologne, Germany
Search for other papers by Maximilian Michel in
Google Scholar
PubMed
Search for other papers by Maximilian Michel in
Google Scholar
PubMed
Christiane Josephine Bruns
Christiane Josephine Bruns
Department of General, Visceral, Tumor and Transplant Surgery, University Hospital Cologne, Cologne, Germany
Search for other papers by Christiane Josephine Bruns in
Google Scholar
PubMed
Search for other papers by Christiane Josephine Bruns in
Google Scholar
PubMed
Hakan Alakus
Hakan Alakus
Department of General, Visceral, Tumor and Transplant Surgery, University Hospital Cologne, Cologne, Germany
Search for other papers by Hakan Alakus in
Google Scholar
PubMed
Search for other papers by Hakan Alakus in
Google Scholar
PubMed
Costanza Chiapponi
Costanza Chiapponi
Department of General, Visceral, Tumor and Transplant Surgery, University Hospital Cologne, Cologne, Germany
Search for other papers by Costanza Chiapponi in
Google Scholar
PubMed
Search for other papers by Costanza Chiapponi in
Google Scholar
PubMed
, randomized, two arms, double blind, placebo controlled, active – not recruiting OS Placebo: 29.0% OS Pazopanib: 37.1% (clinicaltrials.gov) N/A Pembrolizumab, Trametinib and Dabrafenib NCT04675710 Pembrolizumab: PD-1 receptor Dabrafenib: BRAF V
Peiwen Wu
Peiwen Wu
Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
Search for other papers by Peiwen Wu in
Google Scholar
PubMed
Search for other papers by Peiwen Wu in
Google Scholar
PubMed
Dongjie He
Dongjie He
Department of Radiation Oncology, Tangdu Hospital, the Second Affiliated Hospital of Air Force Medical University, Xi’an, China
Search for other papers by Dongjie He in
Google Scholar
PubMed
Search for other papers by Dongjie He in
Google Scholar
PubMed
Hao Chang
Hao Chang
Department of Radiation Oncology, Tangdu Hospital, the Second Affiliated Hospital of Air Force Medical University, Xi’an, China
Search for other papers by Hao Chang in
Google Scholar
PubMed
Search for other papers by Hao Chang in
Google Scholar
PubMed
Xiaozhi Zhang
Xiaozhi Zhang
Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
Search for other papers by Xiaozhi Zhang in
Google Scholar
PubMed
Search for other papers by Xiaozhi Zhang in
Google Scholar
PubMed
(SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study . Lancet. Oncology 2020 21 1500 – 1512 . ( https://doi.org/10.1016/S1470-2045(2030496-4 ) 37 Xu J Shen L Bai C Wang W Li J Yu X Li Z Li E Yuan X Chi Y , et
Kaili Yang
Kaili Yang
Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Search for other papers by Kaili Yang in
Google Scholar
PubMed
Search for other papers by Kaili Yang in
Google Scholar
PubMed
Jiarui Li
Jiarui Li
Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China
Search for other papers by Jiarui Li in
Google Scholar
PubMed
Search for other papers by Jiarui Li in
Google Scholar
PubMed
Yuejuan Cheng
Yuejuan Cheng
Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Search for other papers by Yuejuan Cheng in
Google Scholar
PubMed
Search for other papers by Yuejuan Cheng in
Google Scholar
PubMed
Chunmei Bai
Chunmei Bai
Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Search for other papers by Chunmei Bai in
Google Scholar
PubMed
Search for other papers by Chunmei Bai in
Google Scholar
PubMed
Tomasek J Raderer M Lahner H Voi M Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study . Lancet 2016 387 968 – 977
Eleftherios E Deiktakis
Eleftherios E Deiktakis
Laboratory of Clinical Chemistry, School of Medicine, University of Crete, Heraklion, Greece
Search for other papers by Eleftherios E Deiktakis in
Google Scholar
PubMed
Search for other papers by Eleftherios E Deiktakis in
Google Scholar
PubMed
Eleftheria Ieronymaki
Eleftheria Ieronymaki
Laboratory of Clinical Chemistry, School of Medicine, University of Crete, Heraklion, Greece
Search for other papers by Eleftheria Ieronymaki in
Google Scholar
PubMed
Search for other papers by Eleftheria Ieronymaki in
Google Scholar
PubMed
Peter Zarén
Peter Zarén
Department of Translational Medicine, Lund University, Malmö, Sweden
Search for other papers by Peter Zarén in
Google Scholar
PubMed
Search for other papers by Peter Zarén in
Google Scholar
PubMed
Agnes Hagsund
Agnes Hagsund
Department of Translational Medicine, Lund University, Malmö, Sweden
Search for other papers by Agnes Hagsund in
Google Scholar
PubMed
Search for other papers by Agnes Hagsund in
Google Scholar
PubMed
Elin Wirestrand
Elin Wirestrand
Department of Translational Medicine, Lund University, Malmö, Sweden
Search for other papers by Elin Wirestrand in
Google Scholar
PubMed
Search for other papers by Elin Wirestrand in
Google Scholar
PubMed
Johan Malm
Johan Malm
Department of Translational Medicine, Lund University, Malmö, Sweden
Search for other papers by Johan Malm in
Google Scholar
PubMed
Search for other papers by Johan Malm in
Google Scholar
PubMed
Christos Tsatsanis
Christos Tsatsanis
Laboratory of Clinical Chemistry, School of Medicine, University of Crete, Heraklion, Greece
Search for other papers by Christos Tsatsanis in
Google Scholar
PubMed
Search for other papers by Christos Tsatsanis in
Google Scholar
PubMed
Ilpo T Huhtaniemi
Ilpo T Huhtaniemi
Department of Translational Medicine, Lund University, Malmö, Sweden
Imperial College London, Institute of Reproductive and Developmental Biology, London, UK
Search for other papers by Ilpo T Huhtaniemi in
Google Scholar
PubMed
Imperial College London, Institute of Reproductive and Developmental Biology, London, UK
Search for other papers by Ilpo T Huhtaniemi in
Google Scholar
PubMed
Aleksander Giwercman
Aleksander Giwercman
Department of Translational Medicine, Lund University, Malmö, Sweden
Malmö University Hospital, Reproductive Medicine Center, Malmö, Sweden
Search for other papers by Aleksander Giwercman in
Google Scholar
PubMed
Malmö University Hospital, Reproductive Medicine Center, Malmö, Sweden
Search for other papers by Aleksander Giwercman in
Google Scholar
PubMed
Yvonne Lundberg Giwercman
Yvonne Lundberg Giwercman
Department of Translational Medicine, Lund University, Malmö, Sweden
Search for other papers by Yvonne Lundberg Giwercman in
Google Scholar
PubMed
Search for other papers by Yvonne Lundberg Giwercman in
Google Scholar
PubMed
suppressed ( 11 ). In a study on men assigned to either placebo or 1 month of GnRH antagonist in the absence or presence of testosterone, the main finding was similar; when the testosterone levels decreased also PSA dropped but completely recovered one month
